LLMpediaThe first transparent, open encyclopedia generated by LLMs

coronary artery bypass grafting

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: renal failure Hop 5
Expansion Funnel Raw 54 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted54
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
coronary artery bypass grafting
NameCoronary artery bypass grafting
SpecialtyJohns Hopkins Hospital, Mayo Clinic, Cleveland Clinic

coronary artery bypass grafting is a surgical revascularization procedure developed to treat obstructive coronary artery disease and to restore myocardial perfusion, first performed in iterations during the mid‑20th century. It integrates surgical techniques refined at institutions such as Massachusetts General Hospital, St Thomas' Hospital, and Royal Brompton Hospital with perioperative management advanced at centers including Stanford Hospital, Mount Sinai Hospital (Manhattan), and UCL Hospitals. The procedure influences guidelines from organizations like the American Heart Association, European Society of Cardiology, and the National Institute for Health and Care Excellence.

History

Early conduits and myocardial revascularization experiments in the 19th and early 20th centuries involved pioneers associated with Guy's Hospital, Royal Hospital Chelsea, and Les Invalides interests in vascular surgery. Mid‑20th century developments at Johns Hopkins Hospital and Mayo Clinic paralleled work by surgeons connected to Harvard University, University of Pennsylvania, and UCLA David Geffen School of Medicine. Landmark clinical series published from St Vincent's Hospital (Dublin), Christiaan Barnard Hospital, and Groote Schuur Hospital contributed to global adoption. Trials and policy debates informed by Medicare (United States), National Health Service (United Kingdom), and multicenter consortia like the SYNTAX trial and FREEDOM trial shaped indications and technique evolution.

Indications and patient selection

Indications derive from randomized trials and guideline committees convened by American College of Cardiology, European Association for Cardio‑Thoracic Surgery, and panels including representatives from World Health Organization. Typical indications include multivessel obstructive disease involving proximal left anterior descending disease referenced in studies from Cleveland Clinic, Brigham and Women's Hospital, and Mount Sinai Hospital (Manhattan). Patient selection integrates assessments from diagnostic centers such as Mayo Clinic imaging labs, results of natriuretic peptide testing popularized by work at Karolinska Institutet, and coronary physiology studies influenced by investigators at Imperial College London and University of Oxford. Comorbidity considerations involve collaborations with services at Massachusetts General Hospital, Johns Hopkins Hospital, and chronic disease programs funded by agencies like the National Institutes of Health.

Surgical techniques

Operative strategies evolved through contributions at Harvard Medical School, University of Toronto, and University of Michigan. Techniques include on‑pump median sternotomy popularized at Cleveland Clinic and off‑pump approaches developed in parallel at Hospital of the University of Pennsylvania and Fuwai Hospital. Minimally invasive procedures and robotic assistance have been advanced at Baylor St. Luke's Medical Center, Mount Sinai Hospital (Manhattan), and University of California, San Francisco surgical programs. Hybrid procedures combining percutaneous intervention techniques championed by teams at Columbia University Irving Medical Center and Toronto General Hospital integrate catheterization suites influenced by innovations from Guy's and St Thomas' NHS Foundation Trust.

Graft conduits

Selection of grafts reflects comparative work from centers like Vanderbilt University Medical Center, Stanford Hospital, and Royal Brompton Hospital. Common conduits include the internal mammary artery whose utility was clarified in long‑term analyses from Cleveland Clinic and Brigham and Women's Hospital, radial artery grafts refined by groups at Singapore General Hospital and University of Hong Kong, and saphenous vein grafts with harvesting techniques developed at Johns Hopkins Hospital and Mayo Clinic. Conduit patency studies and registries assembled by consortiums tied to European Society of Cardiology and American Heart Association guide selection based on lesion location and patient profile.

Perioperative care and complications

Perioperative protocols draw on critical care pathways from Intensive Care Unit (ICU) models at St Thomas' Hospital, Johns Hopkins Hospital, and Guy's Hospital. Complications such as myocardial infarction, stroke, wound infection, and renal dysfunction are tracked in registries affiliated with Society of Thoracic Surgeons, National Health Service (United Kingdom), and Agency for Healthcare Research and Quality. Antiplatelet and anticoagulation strategies influenced by trials at Duke University Medical Center, Mount Sinai Hospital (Manhattan), and Oxford University Hospitals interact with blood management programs developed at Mayo Clinic and transfusion guidelines promoted by World Health Organization.

Outcomes and prognosis

Long‑term outcomes are reported in multicenter registries coordinated by Society of Thoracic Surgeons, trials such as SYNTAX trial and FREEDOM trial, and academic centers including Cleveland Clinic, Mayo Clinic, and Brigham and Women's Hospital. Prognosis depends on extent of coronary disease, ventricular function, and comorbidities managed at institutions like Johns Hopkins Hospital and Massachusetts General Hospital. Quality of life and functional outcomes have been studied in cohorts from Mount Sinai Hospital (Manhattan), Karolinska University Hospital, and University of Toronto with economic analyses referenced by National Institute for Health and Care Excellence.

Alternatives and adjunctive therapies

Alternatives include percutaneous coronary intervention techniques developed at Mayo Clinic, Columbia University Irving Medical Center, and Cleveland Clinic, with drug‑eluting stent technology advanced by investigators at Stanford Hospital and Duke University Medical Center. Adjuncts such as myocardial protection solutions and intra‑aortic balloon pump support were refined at Massachusetts General Hospital, Brigham and Women's Hospital, and University of Oxford. Cardiac rehabilitation programs structured by American Heart Association, British Heart Foundation, and World Health Organization complement revascularization strategies.

Category:Cardiac surgery